Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Gemcitabine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | decitabine:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | MI-2 | CTRPv2 | pan-cancer | AAC | 0.02 | 0.7 |
mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | FMK | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |